Rashidul Haque, and Sultana Rajia. “AMP-Kinase Is the Main Target of Metformin in Regulating Type 2 Diabetes”. Research Highlights in Disease and Health Research Vol. 2, Feb. 2023, pp. 83-95, doi:10.9734/bpi/rhdhr/v2/9366F.